This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,092.00 Firm Fixed Price Delivery Order is for the supply of COPAXONE 40 MG/ML SYRINGEML medication, with a completion date of December 4, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is for the supply of 4566719549 units of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $1,092.00 and a completion date of April 2, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,846.69 firm fixed-price delivery order is for the supply of Copaxone 40 mg/mL syringes, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,176.33 firm fixed-price contract is for the supply of COPAXONE 40 MG/ML syringes, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of May 5, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,583.28 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564466149 COPAXONE 40 MG/ML SYRINGEML and has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a $1,583.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML syringes. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Copaxone 40 mg/mL syringes. The contract has a firm fixed price and a ceiling value of $1,638.00. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a $1,728.57 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide COPAXONE 40 MG/ML SYRINGE/ML. The award has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,660.80 delivery order contract is for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm-fixed price delivery order, with an ultimate completion date of June 9, 2025. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant...